Table 1.
Test strains | Clinical condition | Resistance pattern | % CSH | Biofilm formation (OD490)* | Virulence factors production | |||
---|---|---|---|---|---|---|---|---|
Solid medium | Liquid medium | |||||||
Activity inde × (pZ) | ||||||||
Proteinase | Haemolysin | Proteinase (OD280)# | % haemolysis | |||||
C. albicans | ||||||||
C. albicans 01 | Candidemia | KTZ, ICZ, FLZ | 41.30 ± 3.75 | 0.49 ± 0.04 | 0.50 ± 0.04 | 0.63 ± 0.05 | 1.23 ± 0.11 | 41.52 |
C. albicans 02 | -Do- | KTZ, ICZ, FLZ | ND | 0.05 ± 0.01 | 0.78 ± 0.04 | 0.60 ± 0.05 | 0.45 ± 0.02 | 29.10 |
C. albicans 03 | -Do- | KTZ, ICZ, FLZ | 62.11 ± 2.31 | 0.59 ± 0.02 | 0.55 ± 0.03 | 1.0 ± 0.00 | 1.35 ± 0.13 | ND |
C. albicans 04 | -Do- | KTZ, ICZ, FLZ | 61.75 ± 2.85 | 1.36 ± 0.66 | 0.80 ± 0.05 | 1.0 ± 0.00 | 0.42 ± 0.04 | ND |
C. albicans 05 | Urine | AMB, KTZ, ICZ, FLZ | 59.78 ± 4.31 | 1.0 ± 0.08 | 1.0 ± 0.00 | 0.68 ± 0.05 | Nil | 74.68 |
C. albicans 06 | -Do- | AMB, KTZ, ICZ, FLZ | 55.43 ± 3.38 | 1.15 ± 0.10 | 0.60 ± 0.04 | 1.0 ± 0.00 | 0.95 ± 0.04 | ND |
C. albicans 07 | -Do- | AMB, KTZ, ICZ, FLZ | 66.21 ± 2.97 | 0.60 ± 0.03 | 0.71 ± 0.06 | 1.0 ± 0.00 | 0.44 ± 0.03 | ND |
C. albicans 08 | -Do- | KTZ, ICZ, FLZ | ND | 0.28 ± 0.04 | 0.52 ± 0.05 | 1.0 ± 0.00 | 1.18 ± 0.14 | ND |
C. albicans 09 | -Do- | AMB, KTZ, ICZ, FLZ | 55.10 ± 2.75 | 1.12 ± 0.09 | 0.77 ± 0.04 | 0.83 ± 0.05 | 0.85 ± 0.06 | 25.84 |
C. albicans 10 | Vaginitis | AMB, KTZ, ICZ, FLZ | ND | 0.05 ± 0.01 | 0.66 ± 0.05 | 1.0 ± 0.00 | 1.37 ± 0.22 | ND |
C. albicans 11 | -Do- | AMB, KTZ, ICZ, FLZ | ND | 0.2650.03 | 0.75 ± 0.04 | 0.63 ± 0.04 | 0.61 ± 0.05 | 37.33 |
C. albicans 12 | -Do- | AMB, KTZ, ICZ, FLZ | ND | 0.35 ± 0.05 | 0.71 ± 0.04 | 1.0 ± 0.00 | 1.00 ± 0.09 | ND |
C. albicans 13 | -Do- | AMB, KTZ, ICZ, FLZ | 25.78 ± 2.98 | 0.67 ± 0.08 | 0.78 ± 0.05 | 1.0 ± 0.00 | 1.15 ± 0.10 | ND |
C. albicans 14 | -Do- | AMB, KTZ, ICZ, FLZ | 33.45 ± 3.71 | 0.62 ± 0.05 | 0.73 ± 0.06 | 1.0 ± 0.00 | 1.18 ± 0.10 | ND |
C. albicans 15 | -Do- | AMB, KTZ, ICZ, FLZ | 44.59 ± 4.97 | 0.55 ± 0.04 | 1.0 ± 0.00 | 1.0 ± 0.00 | Nil | ND |
C. albicans 16 | -Do- | AMB, KTZ, ICZ, FLZ | 24.76 ± 2.38 | 0.58 ± 0.01 | 1.0 ± 0.00 | 0.65 ± 0.05 | Nil | 83.18 |
C. albicans 17 | -Do- | AMB, KTZ, ICZ, FLZ | 40.90 ± 3.36 | 0.78 ± 0.02 | 1.0 ± 0.00 | 0.64 ± 0.04 | Nil | 81.25 |
C. albicans 18 | -Do- | AMB, KTZ, ICZ, FLZ | 53.45 ± 4.97 | 1.32 ± 0.07 | 1.0 ± 0.00 | 0.68 ± 0.05 | Nil | 91.45 |
C. albicans NRRLY12983 | Reference strain | KTZ, ICZ, FLZ | 25.78 ± .17 | 1.15 ± 0.10 | 0.50 ± 0.04 | 0.73 ± 0.06 | 1.21 ± 0.10 | 24.32 |
C. albicans MTCC183 | -Do- | KTZ, ICZ, FLZ | 35.60 ± 1.76 | 0.60 ± 0.03 | 1.0 ± 0.00 | 0.82 ± 0.06 | 1.35 ± 0.12 | 24.93 |
C. albicans SC5314 | -Do- | - | 63.28 ± 5.18 | 1.09 ± 0.01 | 0.58 ± 0.05 | 0.55 ± 0.06 | 1.06 ± 0.09 | 74.45 |
Non albicans -Candida | ||||||||
C. glabrata 01 | Vaginitis | KTC, ICZ, FLZ | 65.39 ± 6.1 | 0.05 ± 0.01 | 1.0 ± 0.00 | 1.0 ± 0.00 | 0.20 ± 0.05 | ND |
C. glabrata 02 | -Do- | AMB, KTZ, ICZ, FLZ | ND | 0.04 ± 0.09 | 1.0 ± 0.00 | 1.0 ± 0.00 | Nil | 15.96 |
C. glabrata MTCC3019 | Reference strain | KTC, ICZ, FLZ | ND | 0.05 ± 0.09 | 1.0 ± 0.00 | 1.0 ± 0.00 | Nil | ND |
C. krusei 01 | Vaginitis | AMB, KTZ, ICZ, FLZ | 41.22 ± 3.38 | 0.05 ± 0.01 | 0.55 ± 0.04 | 0.61 ± 0.04 | Nil | 28.95 |
C. tropicalis 01 | Candidemia | ICZ, FLZ | 62.99 ± 5.10 | 0.14 ± 0.01 | 0.56 ± 0.04 | 0.63 ± 0.05 | 0.98 ± 0.07 | 60.42 |
C. tropicalis 02 | Vaginitis | ICZ, FLZ | ND | 0.06 ± 0.02 | 0.65 ± 0.05 | 0.66 ± 0.05 | 0.57 ± 0.06 | 34.27 |
pZ = (zone of diameter of colony)/(zone of diameter of colony + zone of solubilization or precipitation around the colony).
pZ = 1; indicates no activity.
*Biofilm formation was considered as Nil for OD490 < 0.1.
OD490 (0.1-0.5); weak biofilm, OD490 (>0.5-1.0); moderate biofilm, OD490 (>1.0); strong biofilms.
#Proteinase activity was considered as Nil for OD280 < 0.1.
AMB; amphotericin B, FLZ; fluconazole, ICZ; Itraconazole, KTZ; ketoconazole.
ND; not detected.